Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D for Oxidative Stress in Impaired Glucose Tolerance
NCT03356873Terminated
- Sponsor
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
- Start
- Sep 2017
- Primary completion
- Jul 2022
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, double-blind trial of vitamin d in Vitamin D deficiency (VDD) and impaired glucose tolerance (IGT), sponsored by Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Primary endpoint: Change in anti-oxidant capacity at 1 month. Started Sep 2017; status: terminated.
02
Drugs
vitamin d
03
Conditions
Vitamin D deficiency (VDD)impaired glucose tolerance (IGT)
Beyond the preview
Go deeper on NCT03356873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03356873.